Donepezil 10 mg tablets: Affected lot may contain over-sized tablets
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Product safety
What you should do
- If your pill bottle of Donepezil 10 mg tablets contains larger-than-normal tablets, or if you are unsure, return it to your pharmacy. Your pharmacist will check it and provide a replacement if needed.
- Contact a health care professional immediately if you notice you or someone you are caring for are experiencing serious side effects.
- Contact Pro Doc Limitée by calling 1-800-361-8559 or emailing medinfo@prodoc.qc.caif you have questions about the recall.
- Report any health product-related side effects or complaints to Health Canada.
- Additional information for health professionals:Health care professionals, such as pharmacists, should check bottles of Donepezil 10 mg tablets before dispensing and report any unusual packages to the company and to Health Canada.
Other Recent Recalls
PDP-DIPHENHYDRAMINE
PDP-DIPHENHYDRAMINE 25 MG and 50 MG CAPSULES: Out-of-specification (Impurity)
Type II2026-11-09
Moderate health risk
Unauthorized injectable peptide and non-peptide drugs
Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs
2026-11-06
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4g/100mL and Potential Bag Leaks
2026-11-03
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.